LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

"Transparent Brain" Expected to Yield Breakthroughs in Understanding Neurological Disorders

By LabMedica International staff writers
Posted on 25 Apr 2013
Print article
Replacement of the brain's fat content with a clear, permeable gel allows optical, fluorescent, and electron microscope studies as well as immunohistochemical analyses to be carried out on intact tissues that have not been damaged or modified by sample preparation techniques.

Investigators at Stanford University (Palo Alto, CA, USA) developed a novel method for creating a "transparent" brain by replacing fat tissue with a clear, permeable gel. The technique was based on infusing a cocktail of reagents, including a plastic-like polymer and formaldehyde, into a mouse brain. When heated, the solution formed a transparent, porous gel that biochemically integrated with, and physically supported, the brain tissue while excluding the lipids, which were removed via an electrochemical process. The process was named CLARITY for Clear Lipid-exchanged Anatomically Rigid Imaging/Immunostaining-compatible Tissue Hydrogel.

A report in the April 10, 2013, online edition of the journal Nature revealed initial results obtained with a CLARITY-treated mouse brain. These results showed intact-tissue imaging of long-range projections, local circuit wiring, cellular relationships, subcellular structures, protein complexes, nucleic acids, and neurotransmitters. CLARITY also enabled intact-tissue in situ hybridization, immunohistochemistry with multiple rounds of staining and de-staining in nonsectioned tissue, and antibody labeling throughout the intact adult mouse brain.

In addition, CLARITY enabled fine structural analysis of clinical samples, including nonsectioned human tissue from a formaldehyde-preserved postmortem human brain from a person who had autism, establishing a path for the transmutation of human tissue into a stable, intact, and accessible form suitable for probing structural and molecular underpinnings of physiological function and disease.

“CLARITY will help support integrative understanding of large-scale, intact biological systems,” said senior author Dr. Karl Deisseroth, professor of bioengineering and of psychiatry and behavioral sciences at Stanford University. “It provides access to subcellular proteins and molecules, while preserving the continuity of intact neuronal structures such as long-range circuit projections, local circuit wiring, and cellular spatial relationships.”

Related Links:
Stanford University


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Automatic Nucleic Acid Extractor
GeneRotex 24

Print article

Channels

Clinical Chemistry

view channel
Image: The new ADLM guidance will help healthcare professionals navigate respiratory virus testing in a post-COVID world (Photo courtesy of 123RF)

New ADLM Guidance Provides Expert Recommendations on Clinical Testing For Respiratory Viral Infections

Respiratory tract infections, predominantly caused by viral pathogens, are a common reason for healthcare visits. Accurate and swift diagnosis of these infections is essential for optimal patient management.... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The novel test uses an existing diagnostic procedure as its basis to target the Epstein Barr Virus (Photo courtesy of 123RF)

Blood Test Measures Immune Response to Epstein-Barr Virus in MS Patients

Multiple sclerosis (MS) is a chronic neurological condition for which there is currently no cure. It affects around three million people globally and ranks as the second most common cause of disability... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more

Pathology

view channel
Image: Insulin proteins clumping together (Photo courtesy of Jacob Kæstel-Hansen)

AI Tool Detects Tiny Protein Clumps in Microscopy Images in Real-Time

Over 55 million individuals worldwide suffer from dementia-related diseases like Alzheimer's and Parkinson's. These conditions are caused by the clumping together of the smallest building blocks in the... Read more

Industry

view channel
Image: For 46 years, Roche and Hitachi have collaborated to deliver innovative diagnostic solutions (Photo courtesy of Roche)

Roche and Hitachi High-Tech Extend 46-Year Partnership for Breakthroughs in Diagnostic Testing

Roche (Basel, Switzerland) and Hitachi High-Tech (Tokyo, Japan) have renewed their collaboration agreement, committing to a further 10 years of partnership. This extension brings together their long-standing... Read more